Background illustration for clinical trials search

Cirrhosis Clinical Trials

Browse 128 Cirrhosis clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1
Featured

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

for
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis,
Location: Burlington MA, East Greenwich RI, Framingham MA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18 - 70+

Code: NCT06419374

Phase 3, Recruiting
Featured

Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

for
Idiopathic Pulmonary Fibrosis
Location: Trois-Rivieres, Philadelphia PA, Richmond VA,
Sponsor: AbbVie

Sex: All

Age: 40+

Code: NCT07230288

Phase 2, Recruiting
Active & Responsive

Prevalence of Gastric Motor Dysfunction and Upper GI Symptoms in Gastric Antral Vascular Ectasias

for
Gastric Antral Vascular Ectasia, Cirrhosis,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 19+

Code: NCT06306963

Recruiting
Active & Responsive

Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease

for
Hepatic Impairment, Cirrhosis, Cholestatic Liver Disease
Location: Indianapolis IN
Sponsor: Zydus Therapeutics Inc.

Sex: All

Age: 18 - 70+

Code: NCT05045482

Phase 1, Recruiting
Active & Responsive

Prehab and Creatine/Whey Supplementation in Frailty Among Patients With Cirrhosis

for
Cirrhosis, Frailty, Sarcopenia
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT07029243

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Biobank for Cholestatic Liver Diseases.

for
Primary Sclerosing Cholangitis, Primary Biliary Cirrhosis,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18 - 70+

Code: NCT03445585

Recruiting
Active & Responsive

SAMe Trial for Patients With Alcoholic Cirrhosis

for
Alcoholic Cirrhosis
Location: Indianapolis IN, Los Angeles CA
Sponsor: Indiana University

Sex: All

Age: 18 - 70

Code: NCT04250259

Phase 2, Recruiting
Active & Responsive

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

for
Rare Disorders, Undiagnosed Disorders,
Location: Sioux Falls SD
Sponsor: Sanford Health

Sex: All

Age: 0+

Code: NCT01793168

Recruiting
Active & Responsive

Pulmonary Fibrosis Foundation Community Registry

for
Pulmonary Fibrosis, Interstitial Lung Disease, Lung Fibrosis,
Location: Chicago IL
Sponsor: Pulmonary Fibrosis Foundation

Sex: All

Age: 18+

Code: NCT05382572

Recruiting
Active & Responsive

Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study

for
Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation
Location: Portland ME, Boston MA, Worcester MA, Lebanon NH,
Sponsor: Chris Goss

Sex: All

Age: 6+

Code: NCT05548283

Recruiting
Active & ResponsiveNew

Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine (NAL) Extended-Release (ER) Tablets

for
Idiopathic Pulmonary Fibrosis
Location: Wilmington DE, North Miami Beach FL, Charlotte NC,
Sponsor: Trevi Therapeutics

Sex: All

Age: 40+

Code: NCT07868419

Phase 3, Recruiting
Active & ResponsiveNew

Study of ORJ-001 for the Treatment of IPF

for
Idiopathic Pulmonary Fibrosis
Location: Doral FL, DuBois PA
Sponsor: Oorja Bio, Inc.

Sex: All

Age: 40+

Code: NCT07869147

Phase 2, Recruiting
Active & Responsive

Interstitial Lung Disease Research Unit Biobank

for
Interstitial Lung Disease, Sarcoidosis,
Location: Kansas City KS
Sponsor: University of Kansas Medical Center

Sex: All

Age: 18+

Code: NCT05392881

Recruiting
Active & Responsive

Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis

for
Idiopathic Pulmonary Fibrosis
Location: Quebec, Trois-Rivieres, Montreal, Ajax, Toronto,
Sponsor: Contineum Therapeutics

Sex: All

Age: 40+

Code: NCT07284459

Phase 2, Recruiting
Active & Responsive

Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

for
Idiopathic Pulmonary Fibrosis (IPF)
Location: North Dartmouth MA, Hialeah FL, DuBois PA,
Sponsor: PureTech

Sex: All

Age: 40+

Code: NCT07284602

Phase 3, Recruiting
Active & Responsive

Nucleoside Therapy in Patients With Telomere Biology Disorders

for
Telomere Biology Disorders, Dyskeratosis Congenita,
Location: Boston MA
Sponsor: Suneet Agarwal

Sex: All

Age: 1 - 70

Code: NCT06817590

Phase 1, Recruiting
Active & Responsive

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

for
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
Location: New Haven CT, New York NY, Philadelphia PA,
Sponsor: Duke University

Sex: All

Age: 21+

Code: NCT01915511

Recruiting
Active & Responsive

PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

for
Progressive Pulmonary Fibrosis, Interstitial Lung Disease
Location: Worcester MA, Charlottesville VA, Ann Arbor MI,
Sponsor: University of Massachusetts, Worcester

Sex: All

Age: 18 - 70+

Code: NCT06855329

Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

for
NASH - Nonalcoholic Steatohepatitis,
Location: South Dartmouth MA, New Haven CT, Manhasset NY,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06528314

Phase 3, Recruiting

Multi-analyte Blood Test Clinical Trial

for
Liver Cirrhosis, Liver Cancer, HCC, Hepatocellular Carcinoma
Location: Gainesville FL, Tampa FL, Waco TX, Edinburg TX,
Sponsor: Helio Genomics

Sex: All

Age: 18+

Code: NCT05199259

Recruiting